TOP STORY | NATIONAL
Ugandan Gynecologists Dismiss Autism Fears Over Panadol Use in Pregnancy
Kampala, Uganda – Ugandan obstetricians and gynecologists have refuted recent media reports linking the use of paracetamol (commonly known as Panadol) during pregnancy to autism spectrum disorder (ASD) in children.
In a statement released on September 26, 2025, the Association of Obstetricians and Gynecologists of Uganda (AOGU) described the claims as based on “weak evidence” that does not justify changes to current medical guidelines.
“Large, recent epidemiological studies have shown no increased risk of autism, attention-deficit/hyperactivity disorder (ADHD), or intellectual disability in children exposed to paracetamol in utero,” the statement reads in part.
ASD is a neurological and developmental condition that affects communication, learning, behavior, and social interaction. Though it can be diagnosed at any age, symptoms typically appear within the first two years of life.
AOGU reaffirmed that paracetamol remains the recommended first-line treatment for managing pain and fever during pregnancy when medically necessary. However, the Association emphasized that it should be used only within recommended dosage limits and for the shortest effective duration.
